Clinical trials sponsored by BrightGene Bio-Medical Technology Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by BrightGene Bio-Medical Technology Co., Ltd.

• A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects
  NCT07239973 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study of BGM0504 in Early T2DM With Obesity
  NCT07743983 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
  NCT07064486 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• A Study of BGM0504 in Participants with Type 2 Diabetes
  NCT06716216 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants
  NCT07294235 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Bioequivalence Study of BGM0504 Injection
  NCT07382908 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects
  NCT07166081 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is BrightGene Bio-Medical Technology Co., Ltd. recruiting for?

BrightGene Bio-Medical Technology Co., Ltd. is the lead sponsor of 7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.